Snowball logo
logo
ADMA_logo

ADMA Biologics, Inc

ADMA β€’ NASDAQ
$9.419-$0.211Β  (2.19%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
80.94154.1258.2426.5510.2512.3
COGS
79.77118.8169.3206.9217.4180.8
Gross Profit
1.17335.2788.94219.6292.8331.5
Operating Expenses & Income
Operating Income
(58.37)(39.37)21.63139191.4216.5
Total Operating Expenses
59.5574.6367.3180.57101.3114.9
R&D Expenses
3.6463.6143.31.8134.76211.52
Selling General & Admin Expenses
55.1970.357.3874.1291.5898.77
Earnings from Continuing Operations
Interest Expense
(13.06)(19.28)(25.03)(13.93)(7.11)(8.825)
Interest Income
0.03450.04481.0068112.0971.8713.194
Income Tax Expense
12.8119.288.164105(71.96)35.7347.52
Net Income
Net Income
(71.65)(65.9)(28.24)197.7146.9169
Supplemental
EBIT
(58.59)(46.63)(3.212)139.6189.8225.3
EBITDA
(53.09)(39.51)5.12147.7197.9234.8
In millions of USD, except % and values per 1 share